MediciNova, Inc. (MNOV)
1.42
0.00 (0.00%)
USD |
NASDAQ |
Oct 19, 16:00
1.42
0.00 (0.00%)
After-Hours: 16:13
MediciNova Cash from Operations (Annual) : -9.810M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -9.810M |
| December 31, 2024 | -10.64M |
| December 31, 2023 | -7.431M |
| December 31, 2022 | -12.91M |
| December 31, 2021 | -9.382M |
| December 31, 2020 | -10.83M |
| December 31, 2019 | -9.125M |
| December 31, 2018 | -9.114M |
| December 31, 2017 | -6.924M |
| December 31, 2016 | -6.546M |
| December 31, 2015 | -7.152M |
| December 31, 2014 | 0.8165M |
| Date | Value |
|---|---|
| December 31, 2013 | -10.65M |
| December 31, 2012 | 10.06M |
| December 31, 2011 | -13.31M |
| December 31, 2010 | -17.70M |
| December 31, 2009 | -17.01M |
| December 31, 2008 | -21.12M |
| December 31, 2007 | -43.86M |
| December 31, 2006 | -34.06M |
| December 31, 2005 | -22.88M |
| December 31, 2004 | -13.55M |
| December 31, 2003 | -5.931M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Viking Therapeutics, Inc. | -278.68M |
| IDEAYA Biosciences, Inc. | -71.10M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |